Meet the killer
First identified by Alois Alzheimer in the early 1900’s, Alzheimer’s Disease (AD) is the prevailing age-related neurodegenerative disorder today. While AD is most commonly associated with dementia and memory loss, it also affects many other functions. It is highly comorbid with other neurodegenerative diseases, including epilepsy (Palop & Mucke 2009), and has an endless list of risk factors which include tumours, diabetes, cardiovascular diseases and infections (de la Torre 2010; Patterson et al. 2007). Despite a wealth of knowledge and research, humanity still has no early diagnosis and no treatment, let alone a cure for AD.
35 million sufferers
There are approximately 35 million people suffering from this terrible fate worldwide. If dementia were a country, it would be around the 35th largest by population in the world, larger than Canada. With a growing population of elderly people, the problem is going to get much, much worse. These numbers are expected to increase dramatically, with estimates ranging from 65 million by 2030 to 115 million by 2050. The suffering is not limited to the Alzheimers patients, as their families, loved ones and caregivers are also put under great emotional and physical burdens.
What we do
We are developing a method that will allow humanity to prevent, stop and reverse Alzheimer’s, epilepsy and other neurodegenerative diseases. The focus of our research is pathology of energy metabolism in the brain and its effect on Alzheimer’s disease. In our most recent study we demonstrate that there is a way to correct this pathology and stop the progression of Alzheimer’s.

Our current research aims to not only stop the progression of Alzheimer’s, epilepsy and other neurodegenerative diseases, but prevent them altogether.
$600 billion annual cost
Not many people are aware of the financial burden AD exerts on society, entire healthcare systems and common taxpayers. In 2010, it was estimated that the worldwide financial cost of AD exceeded $600 billion, the monetary equivalent of the 18th largest economy in the world, between Turkey and Indonesia (alz.co.uk).
  1. Concept
    We have found that by using energy substrate called Pyruvate as a dietary supplement, the toxic effect of Aβ-overproduction is absent. We have found that pyruvate supplementation interrupts the vicious cycle caused by metabolic crisis in the brain, by correcting the underlying energy supply deficiency which triggers AD pathology. Pyruvate is
  2. We need results quickly!
    By raising awareness, we also aim provide a little hope to the millions of people affected by this terrible disease, who currently believe there is no light at the end of the tunnel for both themselves and future sufferers. We sincerely hope that with further research into this approach, and with subsequent clinical trials based on it, that this could be single biggest breakthrough ever in our fight against AD and other neurodegenerative diseases.
  3. Alzheimer's is a trending topic and there are literally thousands of scientific articles being published every year. We have launched this campaign in order to ensure that our promising results are not lost in the sea of AD research, as we believe it is extremely important that people hear about this approach. The main issue at hand is that AD is getting worse and we need results quickly! Besides continuing our research into the metabolic correction of AD, we aim to raise awareness of this approach to both the scientific community as well as the lay public, as this problem concerns us all, and the potential implications/benefits of this
    We have launched this campaign in order to ensure that our promising results are not lost in the sea of AD research, as we believe it is extremely important that people hear about this approach. The main issue at hand is that AD is getting worse and we need results quickly! Besides continuing our research into the metabolic correction of AD, we aim to raise awareness of this approach to both the scientific community as well as the lay public, as this problem concerns us all, and the potential implications/benefits of this approach may prove to be enormous.